Skip to main content

Advertisement

Table 1 Application of magnetic targeting techniques in pre-clinical studies

From: Magnetic targeting as a strategy to enhance therapeutic effects of mesenchymal stromal cells

Target MSC donor MSC recipient Nanoparticle Magnetic device Magnetic device position Reference
Knee joint (cartilage) Human Pigs and rabbits Feridex (Tanabe Seiyaku) Electromagnet External [10]
Rabbit Rabbits Ferucarbotran/Resovist® Permanent magnet External [24]
Meniscus Rabbit Rabbit Ferucarbotran/Resovist® Permanent magnet External [25]
Skeletal muscle Human Rats Risovist® Electromagnet External [23]
Bones Rat Rats Ferucarbotran/Resovist® Permanent magnet External [26]
Spinal cord Rat Rats Poly-l-lysine-coated SPIONs Permanent magnet Implanted [21]
Not reported Rats Not reported Permanent magnet External [20]
Retina Rat Rats FluidMAG-D® Permanent magnet Implanted [27]
Arteries Rabbit Rabbits FluidMAG-D® Permanent magnet External [29]
Heart Rat Rats Ferucarbotran/Resovist® Permanent magnet External [49]
Pig Pigs Gadolinium nanotubes and Molday ION(–)® Permanent magnet Implanted [22]
Rat Rats Ferucarbotran/Resovist® Permanent magnet External [11]
Lung Human Mouse DMSA-coated maghemite nanoparticles Permanent magnet External [33]
  1. DMSA dimercaptosuccinic acid, MSC mesenchymal stromal cell, SPION superparamagnetic iron oxide nanoparticle